Prognostic Analysis of Schistosomal Rectal Cancer

  • Wang, Meng (Department of Gastroenterological Surgery, West China Hospital, Sichuan University) ;
  • Zhang, Yuan-Chuan (Department of Gastroenterological Surgery, West China Hospital, Sichuan University) ;
  • Yang, Xu-Yang (Department of Gastroenterological Surgery, West China Hospital, Sichuan University) ;
  • Wang, Zi-Qiang (Department of Gastroenterological Surgery, West China Hospital, Sichuan University)
  • Published : 2014.11.28


Background: Schistosomiasis is an infectious disease that affects more than 230 million people worldwide, according to conservative estimates. Some studies published from China and Japan reported that schistosomiasis is a risk factor for colorectal cancer in Asia where the infective species is S. japonicum. Hoqwever, there have been only few reports of prognosis of patients with schistosomal rectal cancer SRC. Objectives: This study aimed to analyze differences in prognosis between SRC and non-schistosomal rectal cancer(NSRC) with current treatments. Materials and Methods: A retrospective review of 30 patients with schistosomal rectal cancer who underwent laparoscopic total mesorectal excision operation (TME) was performed. For each patient with schistosomal rectal cancer, a control group who underwent laparoscopic TME with non-schistosomal rectal cancer was matched for age, gender and tumor stage, resulting in 60 cases and controls. Results: Univariate analysis showed pathologic N stage (P=0.006) and pathologic TNM stage (P=0.047) statistically significantly correlated with disease-free survival (DFS). Pathologic N stage (P=0.014), pathologic TNM stage (P=0.002), and with/without schistosomiasis (P=0.026) were statistically significantly correlated with overall survival (OS). Schistosomiasis was the only independent prognostic factor for DFS and OS in multivariate analysis. Conclusions: The prognosis of patients with schistosomal rectal cancer is poorer than with non-schistosomal rectal cancer.


  1. Abe Y, Inamori M, Fujita K, et al (2006). Gastrointestinal: rectal polyp associated with schistosomiasis. J Gastroenterol Hepatol, 21, 1216.
  2. Brenner H, Kloor M, Pox CP. (2014). Colorectal cancer. Lancet, 383, 1490-502.
  3. Canepa M, Fanta PT, Weidner N, Peterson MR (2012). Schistosomiasis and signet ring cell carcinoma of the rectum. Ann Diagn Pathol, 16, 385-7.
  4. Cihan S, Uncu D, Babacan NA, et al (2011). Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma. Asian Pac J Cancer Prev, 12, 967-70.
  5. Colley DG, Bustinduy AL, Secor WE, King CH (2014). Human schistosomiasis. Lancet, 383, 2253-64.
  6. Greene FL (2007). Current TNM staging of colorectal cancer. Lancet Oncol, 8, 572-3.
  7. Gu J, Chen N (2013). Current status of rectal cancer treatment in China. Colorectal Dis, 15, 1345-50.
  8. How P, Shihab O, Tekkis P, et al (2011). A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol, 20, 149-55.
  9. Inoue I, Kato J, Tamai H, Iguchi M, Maekita T, Yoshimura N, Ichinose M (2014). Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms. World J Gastroenterol, 20, 1485-92.
  10. Ishii A, Matsuoka H, Aji T, et al (1994). Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review. Mutat Res, 305, 273-81.
  11. Liao XC, Huang WH, Wu GC (2013). Epidemic monitoring of schistosomiasis in Huangchang Village, Shashi District, from 2005 to 2010. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 25, 543-4.
  12. Liu W, Zeng HZ, Wang QM, e al (2013). Schistosomiasis combined with colorectal carcinoma diagnosed based on endoscopic findings and clinicopathological characteristics: a report on 32 cases. Asian Pac J Cancer Prev, 14, 4839-42.
  13. Matsuda K, Masaki T, Ishii S, (1999). Possible associations of rectal carcinoma with Schistosoma japonicum infection and membranous nephropathy: a case report with a review. Jpn J Clin Oncol, 29, 576-81.
  14. McCoy AN, Araujo-Perez F, Azcarate-Peril A, et al (2013). Fusobacterium is associated with colorectal adenomas. PLoS One, 8, 53653.
  15. Soliman NA, Keshk WA, Shoheib ZS, Ashour DS, Shamloula MM (2014). Inflammation, oxidative stress and L-fucose as indispensable participants in schistosomiasis-associated colonic dysplasia. Asian Pac J Cancer Prev, 15, 1125-31.
  16. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C et al (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2163-96.
  17. Xu Z, Su DL (1984). Schistosoma japonicum and colorectal cancer: an epidemiological study in the People's Republic of China. Int J Cancer, 34, 315-8.
  18. Zaghloul MS (2012). Bladder cancer and schistosomiasis. J Egypt Natl Canc Inst, 24, 151-9.
  19. Zhang R, Takahashi S, Orita S, et al (1998). p53 gene mutations in rectal cancer associated with schistosomiasis japonica in Chinese patients. Cancer Lett, 131, 215-21.

Cited by

  1. Comparison of non-schistosomal rectosigmoid cancer and schistosomal rectosigmoid cancer vol.21, pp.23, 2015,